SHP Wealth Management’s Biogen BIIB Stock Holding History

SHP Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$44.3K	Buy	242 +19	+9%	+$3.5K	﹤0.01%	521
2025 Q4	$39.2K	Buy	+223	New	+$36.4K	﹤0.01%	535

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SHP Wealth Management's BIIB Position: Q1 2026 in Review

SHP Wealth Management increased its Biogen (BIIB) stake by 8.5% in Q1 2026, buying an estimated $3.5K and bringing the position to 242 shares worth $44.3K. The position accounts for ﹤0.01% of the portfolio, ranked #521.

SHP Wealth Management first reported a position in BIIB in Q4 2025 and has held it in 2 quarters since. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

SHP Wealth Management held 242 shares of Biogen worth $44.3K as of Q1 2026.
SHP Wealth Management bought 19 Biogen shares in Q1 2026, an estimated $3.5K.
Biogen made up ﹤0.01% of SHP Wealth Management's portfolio in Q1 2026, its #521 holding.
SHP Wealth Management first reported a position in Biogen in Q4 2025 and has held it in 2 quarters since.
1,009 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on SHP Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.